Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline vs PRP vs Combination for Atrophic Acne Scars
NCT06319768Recruiting
- Sponsor
- Sohag University
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules, Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of pentoxifylline and platelet-rich plasma in atrophic acne scar (3 arms), sponsored by Sohag University. Primary endpoint: Goodman and Baron qualitative grading system of postacne scarring at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
pentoxifyllineplatelet-rich plasma
03
Conditions
atrophic acne scar
Beyond the preview
Go deeper on NCT06319768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319768.